Antiplatelet drugs are mainly used for the treatment and prevention of cardiovascular disorders like coronary artery disease, thrombosis and stroke. These drugs helps in preventing the formation of blood clots by inhibiting platelet activation and aggregation. The increasing prevalence of cardiovascular diseases across the globe due to sedentary lifestyle and changes in dietary patterns has been driving the demand for antiplatelet drugs. As per the World Health Organization, cardiovascular diseases accounted for over 17.9 million deaths in 2019, representing 32% of all global deaths.
The global Antiplatelet Drugs Market is estimated to be valued at US$ 2321.37 Mn in 2023 and is expected to exhibit a CAGR of 0.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising incidence of cardiovascular diseases is one of the major factors augmenting the growth of the global antiplatelet drugs market. As per the Centres for Disease Control and Prevention, around 18.2 million adults aged 20 years and older in the U.S. are estimated to have coronary artery disease. The increasing geriatric population is also contributing to the rising prevalence of heart diseases due to age-related weakening of blood vessels and arteries. For instance, according to the United Nations, the population aged 60 years and above is projected to rise from 962 million globally in 2017 to 2.1 billion by 2050. Growing awareness regarding the preventive benefits of antiplatelet drugs and increasing adoption of sedentary lifestyle in developing countries is expected to propel the antiplatelet drugs market growth over the forecast period.
Segment Analysis
The global antiplatelet drugs market is segmented by indication, distribution channel, and route of administration. Chemotherapy-induced thromboctypia dominates the indication segment as antiplatelet drugs are widely prescribed for reducing the risk of thrombosis due to chemotherapy. The hospital pharmacies sub-segment is dominating the distribution channel segment as hospitals are a major source of antiplatelet drugs and regulate its distribution chain. Oral route of administration sub-segment is expected to dominate due to ease of administration and increase patient compliance to the treatment regime.
Key Takeaways
The global antiplatelet drugs market is expected to witness high growth over the forecast period. The global Antiplatelet Drugs Market is estimated to be valued at US$ 2321.37 Mn in 2023 and is expected to exhibit a CAGR of 0.8% over the forecast period 2023 to 2030.
North America is expected to dominate the market owing to high prevalence of cardiovascular diseases in the region along with developed healthcare infrastructure and focus on research & development of novel drugs in the US and Canada. For instance, the American Heart Association has estimated that cardiovascular diseases account for over 800,000 deaths in the United States each year.
Key players
Key players operating in the antiplatelet drugs market are Air Techniques, Inc., Maguire Refining, Inc., Solmetex, Durr Dental, Medentex GmbH, MARS Bio-Med Processes Inc., Dove Dental Products, METASYS, Crosstex International, Inc., Capsule Technologies Inc., A B Dental Trends, Inc., American Dental Accessories, Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it